Selpercatinib (Retevmo) Report issue

Small molecule Orphan Drug FDA Approved FDA Breakthrough Therapy FDA Accelerated Approval FDA Priority Review FDA
AACT
Back

Drug Pricing Summary

VA Big4

$85.2250 - $128.4135

VA FSS

$109.2685 - $163.9028

Drug Product Pricing

Product $/unit Ctry. List Type
Product (units) Manufacturer
selpercatinib 40 mg (CAPSULE) $85.2250 VA Big4
  • RETEVMO (60)
    		•  Eli Lilly & Company
    selpercatinib 40 mg (CAPSULE) $109.2685 VA FSS
  • RETEVMO (60)
    		•  Eli Lilly & Company
    selpercatinib 80 mg (CAPSULE) $127.8681 VA Big4
  • RETEVMO (120)
    		•  Eli Lilly & Company
    selpercatinib 80 mg (CAPSULE) $128.4135 VA Big4
  • RETEVMO (60)
    		•  Eli Lilly & Company
    selpercatinib 80 mg (CAPSULE) $163.9028 VA FSS
  • RETEVMO (120)
    		•  Eli Lilly & Company
  • RETEVMO (60)
    		•  Eli Lilly & Company

    Note: This drug pricing data is preliminary, incomplete, and may contain errors.

    Feedback

    Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

    Report issue